Abstract A new cytotoxic substance named mechercharmycin A was isolated from marine-derived Thermoactinomyces sp. YM3-251. The structure of mechercharmycin A was determined by an X-ray crystallographic analysis to be cyclic peptide-like and bearing four oxazoles and a thiazole. Mechercharmycin B, a linear congener of mechercharmycin A, was also isolated from the same bacterium. Mechercharmycin A exhibited relatively strong antitumor activity, whereas mechercharmycin B exhibited almost no such activity.
combined, and the mixture was chromatographed on a silica gel column by step-wise elution with chloroform/methanol (1ϳ6% methanol). Antitumor activity was observed in the 4% methanol-chloroform fraction, and this fraction was further separated by HPLC.
Finally, 7 mg of 1 was obtained from a 200-liter culture, and 3 mg of 2 was also obtained from the same fraction. The physico-chemical properties of 1 and 2 are summarized in Table 1 , and the NMR data are presented in Table 2. 290 The molecular formula of 1 was determined to be C 35 H 32 N 8 O 7 S from its HRFAB-MS data ( Table 1 ). The peptide moiety was composed of a dehydroalanine fragment, valine and isoleucine as determined from the 2D NMR data, including COSY, TOCSY, HSQC and HMBC. The remaining structure, which was presumed to contain four consecutive oxazoles and a thiazole from an analysis of the chemical shift of 1 H and 13 C NMR and HMBC signals from aromatic protons to quaternary aromatic carbons, could not be fully determined by the NMR studies, because there was no correlation signal by HMBC between the oxazoles, as in the case of telomestatin [5] . Consequently, the structure of 1 was determined by an Xray crystallographic analysis. The applicable crystal was obtained by crystallization from dichloromethane/methanol (1 : 1). The crystal data and measurement conditions are summarized later [6] , and the ORTEP drawing shown in Figure 2 . The absolute configuration of 1 was determined from an X-ray anomalous dispersion of the S atom as shown in Figure 1 .
The molecular formula of 2 was determined to be C 35 H 36 N 8 O 10 from the HRFAB-MS data ( Table 1 ). The peptide moiety of 2 was determined by NMR studies, this partial structure being the same as that of 1. The remaining partial structures of 2, involving four oxazole ring structures: an oxazole, a 5-phenyloxazole, an oxazole-2-carboxylic acid methyl ester, and an oxazole-4-carboxylic acid amide, were determined from a detailed analysis of the NMR data. The respective connectivity of the oxazole and 5-phenyloxazole was determined by the HMBC signals from H9 to C7 and from N6-H to C22. The connectivity of the oxazole-2-carboxylic acid methyl ester and oxazole-4-carboxylic acid amide was not determined by the NMR studies, but instead by a fragment analysis of the LC-MS/MS data, enabling the complete structure of 2 to be determined as shown in Figure 1 . The absolute stereochemistry of 2 was determined by the Marfey's method [7] and a chiral HPLC analysis.
The cytotoxic activity of 1 was relatively strong, the IC 50 value for A549 cells (human lung cancer) being 4 
